loadpatents
name:-0.014528036117554
name:-0.011007070541382
name:-0.0079619884490967
Bora; Rajesh Onkardas Patent Filings

Bora; Rajesh Onkardas

Patent Applications and Registrations

Patent applications and USPTO patent grants for Bora; Rajesh Onkardas.The latest application filed is for "substituted nitrogen containing compounds".

Company Profile
7.10.12
  • Bora; Rajesh Onkardas - Bangalore IN
  • Bora; Rajesh Onkardas - Aurangabad IN
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Benzofuran derivatives for the treatment of hepatitis C
Grant 11,161,837 - Yeung , et al. November 2, 2
2021-11-02
Substituted Nitrogen Containing Compounds
App 20200339550 - Yadav; Navnath Dnyanoba ;   et al.
2020-10-29
Benzofuran Derivatives For The Treatment Of Hepatitis C
App 20200291002 - Yeung; Kap-Sun ;   et al.
2020-09-17
Substituted bicycle heterocyclic derivatives useful as ROMK channel inhibitors
Grant 10,723,723 - Gunaga , et al.
2020-07-28
Substituted Nitrogen Containing Compounds
App 20200109135 - Yadav; Navnath Dnyanoba ;   et al.
2020-04-09
Substituted nitrogen containing compounds
Grant 10,501,449 - Yadav , et al. Dec
2019-12-10
Substituted Bicycle Heterocyclic Derivatives Useful As Romk Channel Inhibitors
App 20190248769 - Gunaga; Prashantha ;   et al.
2019-08-15
Inhibitors of human immunodeficiency virus replication
Grant 10,221,129 - Bender , et al.
2019-03-05
Compounds for the treatment of hepatitis C
Grant 10,150,747 - Yeung , et al. Dec
2018-12-11
Substituted Nitrogen Containing Compounds
App 20180346453 - Yadav; Navnath Dnyanoba ;   et al.
2018-12-06
Inhibitors Of Human Immunodeficiency Virus Replication
App 20180086697 - BENDER; John A. ;   et al.
2018-03-29
Novel Compounds For The Treatment Of Hepatitis C
App 20180022723 - Yeung; Kap-Sun ;   et al.
2018-01-25
Substituted 4,5,6,7-tetrahydropyrazolo[1,5-A]pyrazine derivatives as casein kinase 1 D/E inhibitors
Grant 9,598,423 - Velaparthi , et al. March 21, 2
2017-03-21
Substituted 4,5,6,7-tetrahydropyrazolo[1,5-a]pyrazine Derivatives As Casein Kinase 1 D/e Inhibitors
App 20160311824 - Velaparthi; Upender ;   et al.
2016-10-27
Novel Substituted Pyrazolo-piperazines As Casein Kinase 1 D/e Inhibitors
App 20160122358 - Velaparthi; Upender ;   et al.
2016-05-05
Substituted pyrazolo-piperazines as casein kinase 1 .delta./.epsilon. inhibitors
Grant 9,273,058 - Velaparthi , et al. March 1, 2
2016-03-01
Novel Substituted Pyrazolo-piperazines As Casein Kinase 1 D/e Inhibitors
App 20150133428 - Velaparthi; Upender ;   et al.
2015-05-14
Compounds for the treatment of hepatitis C
Grant 8,507,683 - Yeung , et al. August 13, 2
2013-08-13
Compounds for the Treatment of Hepatitis C
App 20120309770 - Yeung; Kap-Sun ;   et al.
2012-12-06
Macrolides and ketolides having antimicrobial activity
Grant 8,097,594 - Sindkhedkar , et al. January 17, 2
2012-01-17
Novel macrolides and ketolides having antimicrobial activity
App 20090247478 - Sindkhedkar; Milind Dattatraya ;   et al.
2009-10-01

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed